AN ARTIFICIAL INTELLIGENCE-POWERED MODEL TO PREDICT RESPONSE TO INTRAVESICAL BCG VERSUS GEMCITABINE-DOCETAXEL FOR HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCERVignesh T. Packiam, Michael J. O’Donnell, Ian M. McElree et al.|Urologic Oncology Seminars and Original Investigations|2025Cited by 0